BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform

  July 10, 2025

   · 

  5 min read
• Press Releases

  Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis (“ALS” or “Lou Gehrig’s Disease”)

  July 10, 2025

   · 

  5 min read
• Press Releases

  Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock

  July 10, 2025

   · 

  4 min read
• Press Releases

  Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock

  July 10, 2025

   · 

  3 min read
• Press Releases

  Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025

  July 10, 2025

   · 

  3 min read
• Press Releases

  European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma

  July 10, 2025

   · 

  8 min read
• Press Releases

  U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

  July 10, 2025

   · 

  16 min read
• Press Releases

  KalVista Pharmaceuticals Provides Operational Update and Fiscal Year 2025 Financial Results

  July 10, 2025

   · 

  7 min read
• Press Releases

  Analgesics Market Size to Exceed USD 143.42 Billion by 2034 Rising Chronic Pain and Advancements in Pain Relief Treatments

  July 10, 2025

   · 

  1 min read
• 

  Infectious disease

  Gilead to Provide New HIV Drug to Lower-Income Countries Through Novel Philanthropic Partnership

  The Global Fund to Fight AIDS, Tuberculosis and Malaria will work with Gilead and other private backers to ensure the HIV preventive Yeztugo, approved last month by the FDA, is available in low- and middle-income countries, concurrent with high-income nations.

  July 10, 2025

   · 

  2 min read

   · 

  Tristan Manalac